Loading...
XHKG
1302
Market cap1.16bUSD
Aug 08, Last price  
2.07HKD
1D
-5.05%
1Q
31.85%
Jan 2017
11.29%
IPO
728.00%
Name

LifeTech Scientific Corp

Chart & Performance

D1W1MN
No data to show
P/E
37.49
P/S
6.39
EPS
0.05
Div Yield, %
Shrs. gr., 5y
1.19%
Rev. gr., 5y
14.28%
Revenues
1.30b
+2.88%
104,704,000140,324,000181,475,000231,035,000282,679,000311,606,000352,849,000409,125,000556,698,000668,879,000642,299,000925,334,0001,097,310,0001,267,175,0001,303,699,000
Net income
222m
-15.52%
3,936,00011,830,00032,352,000-65,666,000-81,244,0002,359,000145,652,000163,472,000121,082,000129,200,000216,085,000292,472,000325,337,000263,242,000222,388,000
CFO
0k
-100.00%
44,755,00011,790,00042,523,00034,963,00019,527,000144,313,000126,956,000154,891,000182,300,000274,986,000338,532,000488,853,000388,318,000418,049,0000

Profile

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, Heart, and Konara-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; delivery systems, such as Fustar steerable and SteerEase introducers; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; LawMax dilators; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; manufacturing and trading of materials for hemp; staff training and internal personnel management business; information consulting for investors; and manufacturing and trading of medical devices, as well as technical, consulting, and technology services. It has operations in Mainland China, India, rest of Asia, Europe, South America, Africa, and internationally. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, the People's Republic of China.
IPO date
Nov 10, 2011
Employees
1,393
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,303,699
2.88%
1,267,175
15.48%
1,097,310
18.59%
Cost of revenue
1,129,381
984,049
779,563
Unusual Expense (Income)
NOPBT
174,318
283,126
317,747
NOPBT Margin
13.37%
22.34%
28.96%
Operating Taxes
30,504
68,091
59,307
Tax Rate
17.50%
24.05%
18.66%
NOPAT
143,814
215,035
258,440
Net income
222,388
-15.52%
263,242
-19.09%
325,337
11.24%
Dividends
Dividend yield
Proceeds from repurchase of equity
(20,762)
(471,179)
BB yield
0.20%
4.15%
Debt
Debt current
3,787
6,293
5,037
Long-term debt
6,171
12,299
14,311
Deferred revenue
37,174
Other long-term liabilities
608,119
599,255
142,500
Net debt
(1,593,870)
(1,692,433)
(1,539,939)
Cash flow
Cash from operating activities
418,049
388,318
CAPEX
(200,831)
(335,473)
Cash from investing activities
(453,882)
(458,468)
Cash from financing activities
182,709
(215,201)
FCF
59,375
(201,431)
274,946
Balance
Cash
1,181,888
1,179,312
833,792
Long term investments
421,940
531,713
725,495
Excess cash
1,538,643
1,647,666
1,504,422
Stockholders' equity
3,475,429
1,606,008
1,459,857
Invested Capital
2,549,884
2,326,513
1,605,011
ROIC
5.90%
10.94%
16.39%
ROCE
4.26%
7.20%
10.37%
EV
Common stock shares outstanding
4,394,487
4,446,121
4,405,420
Price
1.39
-40.85%
2.35
-8.91%
2.58
-29.51%
Market cap
6,108,337
-41.54%
10,448,384
-8.07%
11,365,984
-31.94%
EV
4,495,389
8,709,679
10,013,536
EBITDA
174,318
360,285
384,853
EV/EBITDA
25.79
24.17
26.02
Interest
722
632
Interest/NOPBT
0.26%
0.20%